Cell Biochemistry and Biophysics

, Volume 68, Issue 1, pp 185–188

Clinical Investigation of Fasudil for the Prevention of Cerebral Vasospasm in Extracranial Carotid Artery Stenting

  • Juan Liu
  • Guo-en Yao
  • Hua-dong Zhou
  • Xiao-jiang Jiang
  • Peng Xie
Translational Biomedical Research

Abstract

To evaluate fasudil hydrochloride for the prevention of cerebral vasospasm (CVS) in extra-cranial carotid angioplasty and stenting (CAS). We retrospectively analyzed 178 patients with unilateral CAS who were given intravenous fasudil hydrochloride during the perioperative period. CVS, hypotension, stroke, and mortality incidence rates were recorded. Of the cohort studied, 80.9 % patients exhibited no local CVS, asymptomatic vasospasm was observed in 17.4 % patients and symptomatic vasospasm in 1.7 % patients via DSA imaging. All CVS was relieved and symptoms disappeared after intra-arterial infusion of papaverine hydrochloride. Intracerebral hemorrhage occurred in two cases during the perioperative period, one of which resulted in death. CVS is a severe complication of CAS. Fasudil hydrochloride can rapidly relieve cerebral vasospasm, has no selective effect on cerebral vasculature, and little influence on blood pressure. It is suitable for the prevention of CVS during interventional treatment of ischemic cerebrovascular disease.

Keywords

Cerebral vasospasm Fasudil hydrochloride Carotid artery Stenting 

References

  1. 1.
    Pluta, R. M., Hansen-Schwartz, J., Dreier, J., Vajkoczy, P., Macdonald, R. L., Nishizawa, S., et al. (2009). Cerebral vasospasm following subarachnoid hemorrhage: Time for a new world of thought. Neurological Research, 31, 151–158.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Schirmer, C. M., Hoit, D. A., & Malek, A. M. (2008). Iatrogenic vasospasm in carotid artery stent angioplasty with distal protection devices. Neurosurgical Focus, 24(2), E12.PubMedCrossRefGoogle Scholar
  3. 3.
    Brott, T. G., Hobson, R. W., Howard, G., Roubin, G. S., Clark, W. M., Brooks, W., et al. (2010). Stenting versus endarterectomy for treatment of carotid-artery stenosis. New England Journal of Medicine, 363, 11–23.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Müller-Hülsbeck, S., Stolzmann, P., Liess, C., Hedderich, J., Paulsen, F., Jahnke, T., et al. (2005). Vessel wall damage caused by cerebral protection devices: ex vivo evaluation in porcine carotid arteries. Radiology, 235, 454–460.PubMedCrossRefGoogle Scholar
  5. 5.
    Bates, E. R., Babb, J. D., Casey, D. E, Jr, Cates, C. U., Duckwiler, G. R., Feldman, T. E., et al. (2007). ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). Journal of the American College of Cardiology, 49, 126–170.PubMedCrossRefGoogle Scholar
  6. 6.
    Cremonesi, A., Manetti, R., Setacci, F., Setacci, C., & Castriota, F. (2003). Protected carotid stenting: Clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke, 34(8), 1936–1941.PubMedCrossRefGoogle Scholar
  7. 7.
    Coon AL, Colby GP, Mack WJ, Feng L, Meyers P, Sander Connolly E Jr, (2004). Treatment of mechanically-induced vasospasm of the carotid artery in a primate using intra-arterial verapamil: A technical case report. BMC Cardiovasc Disord, 4, 11.Google Scholar
  8. 8.
    Liu, J. K., Tenner, M. S., Gottfried, O. N., Stevens, E. A., Rosenow, J. M., Madan, N., et al. (2004). Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. Journal of Neurosurgery, 100(3), 414–421.PubMedCrossRefGoogle Scholar
  9. 9.
    Mayberg, M. R., Batjer, H. H., Dacey, R., et al. (1994). Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the stroke council. Circulation, 90, 2592–2605.PubMedCrossRefGoogle Scholar
  10. 10.
    Findlay, J. M. (1997). Current management of aneurismal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society. Canadian Journal of Neurological Sciences, 24, 161–170.PubMedGoogle Scholar
  11. 11.
    Rinkel, G. J., Feigin, V. L., Algra, A., van den Bergh, W. M., Vermeulen, M., & van Gijn, J. (2005). Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database System Review, 1, CD000277.Google Scholar
  12. 12.
    Macdonald, R. L., Zhang, J., Sima, B., & Johns, L. (1995). Papaverine-sensitive vasospasm and aeterial contractility and compliance after subarachnoid hemorrhage in dogs. Neurosurgery, 37(5), 962–968.PubMedCrossRefGoogle Scholar
  13. 13.
    Nakajima, M., Date, I., Takahashi, K., et al. (2001). Effects of aging on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke, 32, 620–628.PubMedCrossRefGoogle Scholar
  14. 14.
    Koji, I., Yoshitaka, H., Takuya, K., et al. (2003). Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition. Hypertension, 6, 1337–1343.Google Scholar
  15. 15.
    Shibuya, M., Asano, T., & Sasaki, Y. (2000). Effect of fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. Acta Neurochirurgica, 77, 201–204.Google Scholar
  16. 16.
    Nohria, A., Grunert, M. E., Rikitake, Y., et al. (2006). Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circulation Research, 99, 1426–1432.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Juan Liu
    • 1
  • Guo-en Yao
    • 1
    • 2
    • 3
  • Hua-dong Zhou
    • 1
  • Xiao-jiang Jiang
    • 1
  • Peng Xie
    • 3
  1. 1.Department of Neurology, Daping HospitalThird Military Medical UniversityChongqingChina
  2. 2.Department of NeurologyThe First Affiliated Hospital of General Hospital of PLABeijingChina
  3. 3.Institute of NeuroscienceChongqing Medical UniversityChongqingChina

Personalised recommendations